Telo Genomics (PK) Stock Price - TDSGF

0.112
-0.008 (-6.67%)
0.112
Best deals to access real time data!
Small Cap Pro
Monthly Subscription
for only
$49.05
Canna Trader Pro
Monthly Subscription
for only
$59.99
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Telo Genomics Corporation (PK) TDSGF OTCMarkets Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.008 -6.67% 0.112 0.112 0.112 0.112 0.12 16:25:57
Bid Price Ask Price Spread Spread % News
0.017 5.14 5.12 99.67% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
1 1,020 $ 0.112 $ 114 1,615 0.0041 - 0.5685
Last Trade Time Type Quantity Stock Price Currency
11:36:28 1,020 $ 0.112 USD

Telo Genomics (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.79M 16.01M - $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
65.00 $ - 0.00% - -

more financials information »

Telo Genomics (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical TDSGF Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.120.12330.10960.123,521-0.008-6.67%
1 Month0.1164640.13460.108140.12076692,519-0.00446-3.83%
3 Months0.102450.13460.03770.11070692,2930.009559.32%
6 Months0.100.56850.03770.13634345,1020.01212.0%
1 Year0.00410.56850.00410.07667515,0200.10792,631.71%
3 Years0.42670.56850.00410.145202110,603-0.3147-73.75%
5 Years0.600.8430.00410.299874112,798-0.488-81.33%

Telo Genomics (PK) Description

3DS is a personalized medicine company with a proprietary software platform based on the three-dimensional analysis of chromosomal signatures. The technology is well developed and supported by 16 clinical studies on over 1,500 patients on 13 different cancers and Alzheimer's disease. Depending on the desired application, the technology can measure the stage of disease, rate of progression of disease, drug efficacy, and drug toxicity. The technology is designed to predict the course of disease and to personalize treatment for the individual patient.


Your Recent History
USOTC
TDSGF
Telo Genom..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.